Our results provide evidence of a new-found, pro-invasive function for Blimp1 in p130Cas/ErbB2 invasive breast cancer and describes its regulation, mechanism of action and in vivo functions. The gene discussed is ERBB2; the disease is invasive breast carcinoma.